NCT01531192View on ClinicalTrials.gov

Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Very Low Birth Weight Infants
Interventions
DIETARY_SUPPLEMENT

Lactobacillus reuteri

Lactobacillus reuteri 100 million CFU/day for 3 months

DRUG

Nystatin

50000 unit/3 times a day, both for orally and by orogastric route

Trial Locations (1)

06110

Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology, Ankara

All Listed Sponsors
lead

Zekai Tahir Burak Women's Health Research and Education Hospital

OTHER

NCT01531192 - Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants | Biotech Hunter | Biotech Hunter